Лишманијаза (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Лишманијаза" in Serbian language version.
refsWebsite
Global rank
Serbian rank
doi.org
- Barrett, MP; Croft, SL (2012). „Management of trypanosomiasis and leishmaniasis.”. British medical bulletin. 104: 175—96. PMC 3530408
. PMID 23137768. doi:10.1093/bmb/lds031. - Sundar, S; Chakravarty, J (јануар 2013). „Leishmaniasis: an update of current pharmacotherapy.”. Expert opinion on pharmacotherapy. 14 (1): 53—63. PMID 23256501. doi:10.1517/14656566.2013.755515.
- Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (новембар 2012). „Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.”. The Journal of antimicrobial chemotherapy. 67 (11): 2576—97. PMID 22833634. doi:10.1093/jac/dks275.
- Minodier, P; Parola, P (мај 2007). „Cutaneous leishmaniasis treatment.”. Travel medicine and infectious disease. 5 (3): 150—8. PMID 17448941. doi:10.1016/j.tmaid.2006.09.004.
- Lozano, R (15. 12. 2012). „Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.”. Lancet. 380 (9859): 2095—128. PMID 23245604. doi:10.1016/S0140-6736(12)61728-0.
- Ejazi, SA; Ali, N (јануар 2013). „Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.”. Expert review of anti-infective therapy. 11 (1): 79—98. PMID 23428104. doi:10.1586/eri.12.148.
nih.gov
ncbi.nlm.nih.gov
- Barrett, MP; Croft, SL (2012). „Management of trypanosomiasis and leishmaniasis.”. British medical bulletin. 104: 175—96. PMC 3530408 . PMID 23137768. doi:10.1093/bmb/lds031.
- Sundar, S; Chakravarty, J (јануар 2013). „Leishmaniasis: an update of current pharmacotherapy.”. Expert opinion on pharmacotherapy. 14 (1): 53—63. PMID 23256501. doi:10.1517/14656566.2013.755515.
- Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (новембар 2012). „Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.”. The Journal of antimicrobial chemotherapy. 67 (11): 2576—97. PMID 22833634. doi:10.1093/jac/dks275.
- Minodier, P; Parola, P (мај 2007). „Cutaneous leishmaniasis treatment.”. Travel medicine and infectious disease. 5 (3): 150—8. PMID 17448941. doi:10.1016/j.tmaid.2006.09.004.
- Lozano, R (15. 12. 2012). „Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.”. Lancet. 380 (9859): 2095—128. PMID 23245604. doi:10.1016/S0140-6736(12)61728-0.
- Ejazi, SA; Ali, N (јануар 2013). „Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.”. Expert review of anti-infective therapy. 11 (1): 79—98. PMID 23428104. doi:10.1586/eri.12.148.
who.int
- „Leishmaniasis Fact sheet N°375”. World Health Organization. јануар 2014. Приступљено 17. 2. 2014.
- „Leishmaniasis Magnitude of the problem”. World Health Organization. Приступљено 17. 2. 2014.